[CAS NO. 24697-74-3]  Leonurine

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [24697-74-3]

Catalog
HY-N0741
Brand
MCE
CAS
24697-74-3

DESCRIPTION [24697-74-3]

Overview

MDL-
Molecular Weight311.33
Molecular FormulaC14H21N3O5
SMILESO=C(OCCCCNC(N)=N)C1=CC(OC)=C(O)C(OC)=C1

For research use only. We do not sell to patients.


Summary

Leonurine is an alkaloid isolated from Leonurus artemisia , with anti-oxidative and anti-inflammatory.


In Vitro

Leonurine (0, 5, 10, 20, 40, 80 µM) causes diminution in lipid accumulation, cellular cholesterol content, including total cholesterol (TC), free cholesterol (FC) and cholesteryl ester (CE), and increase in apoA-I- or HDL-mediated cholesterol efflux after treatment for 24 h. Leonurine also significantly and dose-dependently increases the expressions of ABCA1 and ABCG1 at the mRNA and protein levels in human THP-1 macrophages, and such effect is involved in PPARγ [1] . Leonurine hydrochloride (LH) shows protective effect on cell viability of HepG2 and HL-7702 cells incubated with palmitic acid (PA) of free fatty acid (FFA) for 24 h. Leonurine hydrochloride (125, 250, 500 μM) improves cellular lipid accumulation in HepG2 and HL-7702 cells via activating AMPK/SREBP1 pathway [2] . Leonurine (5, 10, 20 µM) inhibits the expression of iNOS, COX-2, PGE2, NO, TNF-α, and IL-6 in IL-1β-induced human chondrocytes, suppresses ECM degradation in human OA chondrocytes, and blocks IL-1β-induced PI3K and Akt phosphorylation in a dose-dependent manner [3] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.


In Vivo

Leonurine (10 mg/kg/d, p.o.) significantly increases the expressions of PPARγ, LXRα, ABCA1 and ABCG1, and decreases both TG and TC levels in serum of mice [1] . Leonurine hydrochloride (50, 100, 200 mg/kg) improves intracellular lipid accumulation via activating AMPK/SREBP1 pathway, enhances biochemical parameters, reduces hepatic lipoperoxide and increases antioxidant levels in mice [2] . Leonurine (20 mg/kg, p.o.) ameliorates osteoarthritis development in mouse DMM model [3] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.


Appearance

Solid



Shipping

Room temperature in continental US; may vary elsewhere.


Storage

4°C, sealed storage, away from moisture

* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)


Solvent & Solubility

In Vitro:

DMSO : 33.33 mg/mL ( 107.06 mM ; ultrasonic and adjust pH to 2 with HCl)

H 2 O : 1 mg/mL ( 3.21 mM ; ultrasonic and warming and heat to 80°C)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 3.2120 mL 16.0601 mL 32.1203 mL
5 mM 0.6424 mL 3.2120 mL 6.4241 mL
10 mM 0.3212 mL 1.6060 mL 3.2120 mL
* Please refer to the solubility information to select the appropriate solvent.


Synonyms

Benzoic acid, 4-hydroxy-3,5-dimethoxy-, 4-[(aminoiminomethyl)amino]butyl ester
Benzoic acid, 4-hydroxy-3,5-dimethoxy-, ester with (4-hydroxybutyl)guanidine
Leonurine
Guanidine, (4-hydroxybutyl)-, 4-hydroxy-3,5-dimethoxybenzoate (ester)
Guanidine, (4-hydroxybutyl)-, 4-hydroxy-3,5-dimethoxybenzoate
4-Hydroxy-3,5-dimethoxybenzoic acid δ-guanidinobutyl ester
Syringic acid δ-guanidinobutyl ester
[4-(4-Hydroxy-3,5-dimethoxybenzoyloxy)butyl]guanidine
4-Guanidino-1-butanol syringate
Leonurin
SCM 198